IVZ vs BEN

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 11, 2026

IVZ

63.5
AI Score
VS
IVZ Wins

BEN

41.3
AI Score

Investment Advisor Scores

IVZ

Nov 11, 2026
64score
Recommendation
STRONG BUY

BEN

Nov 11, 2026
41score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric IVZ BEN Winner
Forward P/E 8.9767 11.2486 IVZ
PEG Ratio 0.9008 0.4462 BEN
Revenue Growth 14.2% 3.9% IVZ
Earnings Growth -1.5% 245.2% BEN
Tradestie Score 63.5/100 41.3/100 IVZ
Profit Margin -1.1% 11.4% BEN
Beta 1.00 1.00 Tie
Implied Volatility N/A N/A Tie
AI Recommendation STRONG BUY HOLD IVZ

Relative Price Performance (Last 90 Days)

IVZ 1M: -1.0% · 3M: -11.5% BEN 1M: +16.4% · 3M: +7.2%

Current Technical Phase

IVZ

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 49

RSI (14): 48.6 · Price: $28.63

BEN

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 69

RSI (14): 69.0 · Price: $36.30

Fundamentals Snapshot

Metric IVZ BEN
Market Cap — —
Forward P/E 8.7 11.5
Trailing P/E — 18.4
Revenue (TTM) — —
Revenue Growth 0.1% 0.0%
Gross Margin 0.3% 0.3%
Operating Margin 0.2% 0.1%
EPS -0.69 1.97
Dividend Yield 0.03% 0.04%

Frequently Asked Questions

Based on our detailed analysis, IVZ is currently the stronger investment candidate, winning 4 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.